April 25, 2018

IU Prepares For Phase 2 Of Grand Challenges Addiction Initiative

Robin Newhouse speaks at an opioid conference hosted by the Indiana Clinical and Translational Sciences Institute Wednesday. - Steve Burns/WTIU-WFIU News

Robin Newhouse speaks at an opioid conference hosted by the Indiana Clinical and Translational Sciences Institute Wednesday.

Steve Burns/WTIU-WFIU News

Indiana University leaders are preparing for the second phase of the university’s effort to tackle the state’s addiction crisis.

President Michael McRobbie announced in October IU would partner with the state and invest $50 million to tackle the opioid epidemic as part of the university’s Grand Challenges initiative.

Sixteen projects launched in January as part of the first phase of the initiative, delving into several different topics, including research and policy analysis.

Read More: IU Creates New Research Position To Combat Opioid Epidemic

Robin Newhouse, the dean of the Indiana University School of Nursing and the lead investigator for IU’s response to addictions, says they’re already learning from the projects.

“We have held many listening sessions, local conversations, two scoping reviews,” Newhouse says. “In another week, we’ll be holding ideas labs, so we can think differently about super ordinate goals associated with how we tackle this addiction crisis.”

Newhouse says the goals of the massive initiative include reducing the number of drug related deaths and substance abuse disorders as a whole, and to reduce the number of babies born with neonatal abstinence syndrome, an opiate dependency.

The first report from one of the phase one projects will be released Thursday with recommendations on how policy can help the opioid crisis.

Support independent journalism today. You rely on WFYI to stay informed, and we depend on you to make our work possible. Donate to power our nonprofit reporting today. Give now.

 

Related News

FSSA creates waitlist for Aged and Disabled waiver. Advocates worry it creates barrier to care
What's at stake in the Supreme Court mifepristone case
Psilocybin research fund, pharmacy benefits manager language added to nursing bill